Copyright
©The Author(s) 2016.
World J Gastroenterol. Jun 21, 2016; 22(23): 5332-5341
Published online Jun 21, 2016. doi: 10.3748/wjg.v22.i23.5332
Published online Jun 21, 2016. doi: 10.3748/wjg.v22.i23.5332
Figure 1 Development of cytotoxic and targeted agents for the treatment of colorectal cancer.
1KRAS wide-type patients. CRC: Colorectal cancer; 5-FU: 5-fluorouracil; LV: Leucovorin; IFL: Irinotecan + 5-fluorouracil + leucovorin; FOLFOXIRI: Leucovorin + 5-fluorouracil + oxaliplatin + irinotecan.
- Citation: Wen F, Li Q. Treatment dilemmas of cetuximab combined with chemotherapy for metastatic colorectal cancer. World J Gastroenterol 2016; 22(23): 5332-5341
- URL: https://www.wjgnet.com/1007-9327/full/v22/i23/5332.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i23.5332